What are the top disease areas for clinical drug trials?
Drug Discovery World
FEBRUARY 20, 2023
The approval was based on results from the PROpel Phase III trial, however, the drug was rejected by UK regulator NICE because it requires expensive genetic testing. The post What are the top disease areas for clinical drug trials? appeared first on Drug Discovery World (DDW).
Let's personalize your content